Verona Pharma (VRNA)
(Real Time Quote from BATS)
$37.21 USD
-1.18 (-3.07%)
Updated Nov 6, 2024 03:12 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/6/25 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | -24.44% |
ABR | 1.00 |
Earnings ESP
|
25.15% |
---|---|
Current Year | -2.09 |
Next Year | -1.36 |
EPS (TTM) | -1.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.71M | 13.55M | 12.24M | 103.49M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 15.19M | 20.51M | 20.82M | 123.62M |
Low Estimate | 4.64M | 8.00M | 7.64M | 73.02M |
Year ago Sales | 0.00M | 0.00M | 0.46M | 12.24M |
Year over Year Growth Est. | NA | NA | 2,572.49% | 745.47% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.40 | -2.09 | -1.36 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | -1.20 |
High Estimate | -0.32 | -0.32 | -2.00 | -1.04 |
Low Estimate | -0.56 | -0.48 | -2.24 | -1.67 |
Year ago EPS | -0.16 | -0.32 | -0.72 | -2.09 |
Year over Year Growth Est. | -168.75% | -25.00% | -190.28% | 35.05% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 0 | 1 |
Up Last 30 Days | 1 | 1 | 0 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 4 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.40 | -2.09 | -1.36 |
7 Days Ago | -0.45 | -0.42 | -2.07 | -1.54 |
30 Days Ago | -0.45 | -0.42 | -2.07 | -1.58 |
60 Days Ago | -0.45 | -0.42 | -2.07 | -1.60 |
90 Days Ago | -0.45 | -0.40 | -1.58 | -1.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.32 | -2.08 | -1.28 |
Zacks Consensus Estimate | -0.43 | -0.40 | -2.09 | -1.36 |
Earnings ESP | 25.15% | 19.50% | 0.48% | 5.71% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.88 | -0.32 | -0.16 | NA |
Estimate | -0.45 | -0.35 | -0.24 | -0.23 | NA |
Difference | -0.11 | -0.53 | -0.08 | 0.07 | -0.16 |
Surprise | -24.44% | -151.43% | -33.33% | 30.43% | -44.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more